DYADIC INTERNATIONAL
1.9100
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.0200
-1.04%
Today's range
1.7900 - 2.0000
ISIN
N/A
Source
NASDAQ
-
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
09 Aug 2023 16:00:00 By Nasdaq GlobeNewswire
-
07 Aug 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
26 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
21 Jun 2023 08:33:24 By Nasdaq GlobeNewswire
-
Dyadic to Participate at Upcoming Events in June
01 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
10 May 2023 16:00:00 By Nasdaq GlobeNewswire
-
Dyadic to Participate at Two Industry Events in May
10 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic Announces Collaboration to Commercialize Animal-Free Alternative Proteins Using Dapibus™
08 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
26 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
18 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic to Present at World Vaccine Congress Washington 2023
30 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic Reports 2022 Year End Results and Recent Company Progress
29 Mar 2023 16:00:00 By Nasdaq GlobeNewswire
-
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
15 Mar 2023 08:30:01 By Nasdaq GlobeNewswire
-
07 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
01 Mar 2023 08:30:05 By Nasdaq GlobeNewswire
-
Dyadic to Participate in Two Upcoming Investor Conferences
02 Feb 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic Announces Sale of Equity Interest in Alphazyme
19 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
04 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
14 Dec 2022 08:30:00 By Nasdaq GlobeNewswire